Sensorion Announces the End of Patient Inclusion in NOTOXIS Phase 2a Clinical Trial of SENS-401 for the Prevention of Cisplatin-Induced Ototoxicity

8 months ago 25
Read Entire Article
  1. Homepage
  2. Finance
  3. Sensorion Announces the End of Patient Inclusion in NOTOXIS Phase 2a Clinical Trial of SENS-401 for the Prevention of Cisplatin-Induced Ototoxicity

Related

Major music labels strike licensing deals with AI streaming startup Klay, Bloomberg News reports

Major music labels strike licensing deals with AI streaming ...

21 minutes ago 2
Earnings call transcript: Agora's Q3 2025 growth driven by AI innovation

Earnings call transcript: Agora's Q3 2025 growth driven by A...

21 minutes ago 2
Oil rebounds as deadline on US sanctions waiver looms

Oil rebounds as deadline on US sanctions waiver looms

21 minutes ago 1

Trending

1. pascal siakam
2. hardy
3. eric reibe
4. hurricanes vs wild
5. lamelo ball
6. arc raiders down
7. bulls vs trail blazers
8. steven wilson
9. illinois basketball
10. mauricio dubon

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

9 months ago 606
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

8 months ago 479
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

8 months ago 326
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

10 months ago 297
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

8 months ago 283
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved